Bedel Financial Consulting, Inc. Bristol Myers Squibb CO Transaction History
Bedel Financial Consulting, Inc.
- $737 Million
- Q2 2025
A detailed history of Bedel Financial Consulting, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 5,830 shares of BMY stock, worth $268,588. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,830
Previous 5,861
0.53%
Holding current value
$268,588
Previous $357,000
24.65%
% of portfolio
0.04%
Previous 0.05%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...